Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate (Q42012562)

15 October 2017

Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphate (English)

1 reference

15 October 2017

1 reference

1 reference

Ofosu FA

1

1 reference

15 October 2017

Modi GJ

2

1 reference

15 October 2017

Blajchman MA

3

1 reference

15 October 2017

Buchanan MR

4

1 reference

15 October 2017

Johnson EA

5

1 reference

15 October 2017

language of work or name

English

0 references

publication date

1 December 1987

1 reference

15 October 2017

1 reference

15 October 2017

248

1 reference

15 October 2017

3

1 reference

15 October 2017

889-896

1 reference

The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

Cell-surface glycosaminoglycans

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

Detection of a new heparin-dependent inhibitor of thrombin in human plasma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

Platelet antiheparin activity. Assay based on factor-Xa inactivation by heparin and antifactor Xa.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

Factor-Xa inactivation by antithrombin. 3. Evidence for biological stabilization of factor Xa by factor V-phospholipid complex.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

Structure and biological activity of heparin.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

The importance of thrombin inhibition for the expression of the anticoagulant activities of heparin, dermatan sulphate, low molecular weight heparin and pentosan polysulphate

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

Glycosaminoglycans and Their Binding to Biological Macromolecules

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

Structure-function relationships of heparin species

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

Distribution of acidic glycosaminoglycans in the intima, media and adventitia of bovine aorta and their anticoagulant properties

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1148633

Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III

17 August 2018

1 reference

12 December 2020

Correlation between structure, fat-clearing and anticoagulant properties of heparins and heparan sulphates

1 reference

12 December 2020

Prolongation of thrombus-formation time in rabbits given chondroitin sulfate A

1 reference

12 December 2020

The isolation of prothrombin, Factor IX and Factor X from human Factor IX concentrates

1 reference

12 December 2020

The heterogeneity of heparins

1 reference

12 December 2020

Characterisation and separation of sulphated glycosaminoglycuronans

1 reference

12 December 2020

Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways

1 reference

12 December 2020

Inhibitory effects of human aortic and venous acid glycosaminoglycans on thrombus formation

1 reference

12 December 2020

Lead precipitation: an aid to separation of dermatan and mucokeratan sulfates from glycosaminoglycan mixtures

1 reference

12 December 2020

Anticoagulant activity of heparin: isolation of antithrombin-binding sites

1 reference

12 December 2020

A conductimetric method for the determination of sulphate and carboxyl groups in heparin and other mucopolysaccharides

1 reference

12 December 2020

Activation of factor X and prothrombin in antithrombin-III depleted plasma: the effects of heparin

1 reference

12 December 2020

Anticoagulant Activity of Human Arterial Mucopolysaccharides

1 reference

12 December 2020

Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity

1 reference

12 December 2020

Biosynthesis of heparin. Substrate specificity of heparosan N-sulfate D-glucuronosyl 5-epimerase

1 reference

12 December 2020

The anticoagulant effect of chondroitin-4-sulfate

1 reference

12 December 2020

In vitro comparison of the antithrombic action of heparin and chondroitinsulfuric acid-B

1 reference

12 December 2020

Heparan sulphates from porcine intestinal mucosa. Preparation and physicochemical properties

1 reference

12 December 2020

Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis

1 reference

12 December 2020

Identifiers

DOI

10.1042/BJ2480889

1 reference

15 October 2017

1 reference

15 October 2017

1 reference